United States Biotechnology & Medical Research

Lisata Therapeutics Inc (LSTA)

Track

Lisata Therapeutics Inc. has recorded no insider trading activity within the last three months. The most recent transaction occurred on December 8, 2021, involving a purchase of shares. Historical data shows a mix of buy and sell transactions by various insiders, with the last recorded activity dating back several years.
Ticker: LSTA Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Lisata Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
MYERS STEVEN S
1 purchase — total 30,190 USD
Buy 8 Dec 2021
Value US$3,475,377.15 | Price 362.56 | Shares 69,830
Buy 9 Sep 2020
Value US$2,232,326.14 | Price 283.26 | Shares 64,109
Planned sale 7 Feb 2017
Value US$31,375.24 | Price 4.77 | Shares 6,575
Planned sale 6 Feb 2017
Value US$2,375.00 | Price 4.75 | Shares 500
Planned sale 3 Feb 2017
Value US$7,256.26 | Price 4.76 | Shares 1,525
Planned sale 2 Feb 2017
Value US$6,650.98 | Price 4.75 | Shares 1,400
Planned sale 2 Feb 2017
Value US$22,547.00 | Price 4.51 | Shares 5,000
Sale 21 Nov 2016
Value US$2,100.00 | Price 4.20 | Shares 500
Planned sale 1 Jul 2016
Value US$9,786.76 | Price 0.61 | Shares 16,094
Planned sale 30 Jun 2016
Value US$42,986.41 | Price 0.60 | Shares 71,406
Planned sale 24 Jun 2016
Value US$8,421.60 | Price 0.55 | Shares 15,312
Planned sale 23 Jun 2016
Value US$4,062.30 | Price 0.55 | Shares 7,386
Sale 6 Mar 2016
Value US$9,103.60 | Price 0.55 | Shares 16,552
Sale 6 Feb 2016
Value US$33,436.80 | Price 0.55 | Shares 60,750
Buy 17 Aug 2015
Value US$27,922.00 | Price 1.40 | Shares 20,000
Buy 12 Aug 2015
Value US$16,681.36 | Price 1.35 | Shares 12,385
Buy 11 Aug 2015
Value US$100,172.70 | Price 1.24 | Shares 81,000
Sale 18 Mar 2015
Value US$320,000.00 | Price 3.20 | Shares 100,000
Sale 9 Dec 2014
Value US$49,204.02 | Price 3.53 | Shares 13,940
Buy 9 Dec 2014
Value US$52,408.50 | Price 3.49 | Shares 15,000
Sale 8 Dec 2014
Value US$60,225.00 | Price 3.75 | Shares 16,060
Buy 5 Dec 2014
Value US$18,744.50 | Price 3.75 | Shares 5,000
Sale 3 Dec 2014
Value US$23,818.27 | Price 4.03 | Shares 5,912
Sale 2 Dec 2014
Value US$24,352.00 | Price 4.00 | Shares 6,088
Buy 1 Dec 2014
Value US$19,247.50 | Price 3.85 | Shares 5,000
Buy 28 Nov 2014
Value US$19,946.00 | Price 3.99 | Shares 5,000
Buy 25 Nov 2014
Value US$59,850.00 | Price 3.99 | Shares 15,000
Buy 25 Nov 2014
Value US$39,850.00 | Price 3.99 | Shares 10,000
Buy 24 Nov 2014
Value US$50,150.00 | Price 4.01 | Shares 12,500
Buy 24 Nov 2014
Value US$78,081.30 | Price 3.94 | Shares 19,800
Sale 12 Dec 2013
Value US$73,124.73 | Price 5.99 | Shares 12,218
Sale 9 Dec 2013
Value US$77,051.52 | Price 6.37 | Shares 12,096
Sale 9 Dec 2013
Value US$77,051.52 | Price 6.37 | Shares 12,096
Sale 6 Dec 2013
Value US$2,755.90 | Price 6.35 | Shares 434
Sale 6 Dec 2013
Value US$2,755.90 | Price 6.35 | Shares 434
Sale 26 Nov 2013
Value US$62,620.00 | Price 6.26 | Shares 10,000
Sale 26 Nov 2013
Value US$62,620.00 | Price 6.26 | Shares 10,000
Buy 12 Nov 2013
Value US$50,075.00 | Price 6.25 | Shares 8,012
Sale 28 Dec 2012
Value US$57,386.05 | Price 0.59 | Shares 96,577
Sale 28 Dec 2012
Value US$29,635.00 | Price 0.59 | Shares 50,000
Sale 27 Dec 2012
Value US$1,664.69 | Price 0.61 | Shares 2,729
Buy 18 Sep 2012
Value US$24,840.00 | Price 0.69 | Shares 36,000
Sale 18 Sep 2012
Value US$24,840.00 | Price 0.69 | Shares 36,000
Buy 15 Dec 2011
Value US$58.48 | Price 0.58 | Shares 100
Buy 15 Dec 2011
Value US$1,699.40 | Price 0.59 | Shares 2,900
Buy 15 Dec 2011
Value US$6,000.00 | Price 0.60 | Shares 10,000
Buy 14 Dec 2011
Value US$23,600.00 | Price 0.59 | Shares 40,000
Buy 14 Dec 2011
Value US$29,890.00 | Price 0.60 | Shares 50,000
Buy 13 Dec 2011
Value US$1,718.25 | Price 0.59 | Shares 2,900
Buy 13 Dec 2011
Value US$650.65 | Price 0.59 | Shares 1,100
Buy 9 Dec 2011
Value US$556.80 | Price 0.56 | Shares 1,000
Buy 3 Mar 2011
Value US$250,000.64 | Price 1.28 | Shares 195,313
Buy 3 Mar 2011
Value US$249,999.36 | Price 1.28 | Shares 195,312
Buy 3 Mar 2011
Value US$100,000.00 | Price 1.28 | Shares 78,125
Buy 28 Feb 2011
Value US$7,854.08 | Price 1.28 | Shares 6,136
Sale 18 Aug 2010
Value US$120,000.00 | Price 1.50 | Shares 80,000
Buy 18 Aug 2010
Value US$120,000.00 | Price 1.50 | Shares 80,000
Buy 18 Feb 2010
Value US$1,000,000.35 | Price 1.35 | Shares 740,741
Buy 18 Feb 2010
Value US$1,000,000.35 | Price 1.35 | Shares 740,741
Buy 18 Feb 2010
Value US$270,000.00 | Price 1.35 | Shares 200,000
Buy 8 Jan 2010
Value US$150,123.52 | Price 1.09 | Shares 137,728
Sale 8 Jan 2010
Value US$150,123.52 | Price 1.09 | Shares 137,728
Buy 14 Aug 2007
Value US$54,450,000.00 | Price 16,500.00 | Shares 3,300
Buy 6 Feb 2007
Value US$0.00 | Price 0.00 | Shares 20,000
Buy 6 Feb 2007
Value US$0.00 | Price 0.00 | Shares 20,000
Buy 26 Jan 2007
Value US$0.00 | Price 0.00 | Shares 200,000
Sale 5 Jun 2006
Value US$18,000.00 | Price 0.06 | Shares 300,000
Buy 2 Jun 2006
Value US$22,000.00 | Price 0.04 | Shares 500,000
Buy 4 Apr 2006
Value US$10,600.00 | Price 0.05 | Shares 200,000
Buy 22 Dec 2005
Value US$24,999.96 | Price 0.06 | Shares 416,666
Buy 30 Nov 2005
Value US$0.00 | Price 0.00 | Shares 595,000
Buy 30 Nov 2005
Value US$0.00 | Price 0.00 | Shares 425,000
Buy 30 Nov 2005
Value US$0.00 | Price 0.00 | Shares 1,700,000
Buy 3 Oct 2005
Value US$10,432.68 | Price 0.04 | Shares 260,817
Buy 16 Aug 2005
Value US$49,999.98 | Price 0.06 | Shares 833,333
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2021-12-10 2021-12-08 B Purchase
MYERS STEVEN S
Non-Executive Director
69,830 +5.3%
362.56
US$3,475,377 		69,830 +5.3% 362.56 US$3,475,377
2020-09-10 2020-09-09 B Purchase
3.1
Davidson Michael H.
Non-Executive Director
64,109 -31.8%
283.26
US$2,232,326 		64,109 -31.8% 283.26 US$2,232,326
2017-02-08 2017-02-07 PlS Planned sale Wei Eric
63,760 +36.3%
148.01
US$4,067,342 		63,760 +36.3% 148.01 US$4,067,342
2017-02-06 2017-02-06 PlS Planned sale Wei Eric
500 -0.3%
4.75
US$2,375 		500 -0.3% 4.75 US$2,375
2017-02-06 2017-02-03 PlS Planned sale Wei Eric
1,525 -0.8%
4.76
US$7,256 		1,525 -0.8% 4.76 US$7,256
2017-02-06 2017-02-02 PlS Planned sale Wei Eric
1,400 -0.8%
4.75
US$6,651 		1,400 -0.8% 4.75 US$6,651
2017-02-06 2017-02-02 PlS Planned sale Wei Eric
5,000 -2.7%
4.51
US$22,547 		5,000 -2.7% 4.51 US$22,547
2016-11-25 2016-11-21 S Sale Wei Eric Non-Executive Director
500 -0.0%
4.20
US$2,100 		500 -0.0% 4.20 US$2,100
2016-07-05 2016-07-01 PlS Planned sale Wei Eric Non-Executive Director
16,094 -0.9%
0.61
US$9,787 		16,094 -0.9% 0.61 US$9,787
2016-07-05 2016-06-30 PlS Planned sale Wei Eric Non-Executive Director
71,406 -3.6%
0.60
US$42,986 		71,406 -3.6% 0.60 US$42,986
2016-06-27 2016-06-24 PlS Planned sale Wei Eric Non-Executive Director
15,312 -0.8%
0.55
US$8,422 		15,312 -0.8% 0.55 US$8,422
2016-06-27 2016-06-23 PlS Planned sale Wei Eric Non-Executive Director
7,386 -0.4%
0.55
US$4,062 		7,386 -0.4% 0.55 US$4,062
2016-06-06 2016-03-06 S Sale Wei Eric Non-Executive Director
16,552 -0.8%
0.55
US$9,104 		16,552 -0.8% 0.55 US$9,104
2016-06-06 2016-02-06 S Sale Wei Eric Non-Executive Director
60,750 -2.9%
0.55
US$33,437 		60,750 -2.9% 0.55 US$33,437
2015-08-18 2015-08-17 B Purchase Mazzo David J

Chief Executive Officer

Executive Director
20,000 +8.3%
1.40
US$27,922 		20,000 +8.3% 1.40 US$27,922
2015-08-13 2015-08-12 B Purchase VATERS ROBERT S

President & CFO

Executive Director
12,385 +5.7%
1.35
US$16,681 		12,385 +5.7% 1.35 US$16,681
2015-08-11 2015-08-11 B Purchase VATERS ROBERT S

President & CFO

Executive Director
81,000 +59.8%
1.24
US$100,173 		81,000 +59.8% 1.24 US$100,173
2015-03-20 2015-03-18 S Sale Wei Eric Non-Executive Director
100,000 -4.5%
3.20
US$320,000 		100,000 -4.5% 3.20 US$320,000
2015-01-02 2014-12-09 S Sale RimAsia Capital Partners, L.P. Non-Executive Director Large shareholder
13,940 -0.6%
3.53
US$49,204 		13,940 -0.6% 3.53 US$49,204
2014-12-09 2014-12-09 B Purchase MYERS STEVEN S Non-Executive Director
15,000 +21.6%
3.49
US$52,408 		15,000 +21.6% 3.49 US$52,408
2014-12-09 2014-12-08 S Sale RimAsia Capital Partners Manager, Ltd. Non-Executive Director Large shareholder
16,060 -0.7%
3.75
US$60,225 		16,060 -0.7% 3.75 US$60,225
2014-12-09 2014-12-05 B Purchase MYERS STEVEN S Non-Executive Director
5,000 +7.8%
3.75
US$18,744 		5,000 +7.8% 3.75 US$18,744
2014-12-04 2014-12-03 S Sale RimAsia Capital Partners Manager, Ltd. Non-Executive Director Large shareholder
5,912 -0.3%
4.03
US$23,818 		5,912 -0.3% 4.03 US$23,818
2014-12-04 2014-12-02 S Sale RimAsia Capital Partners Manager, Ltd. Non-Executive Director Large shareholder
6,088 -0.3%
4.00
US$24,352 		6,088 -0.3% 4.00 US$24,352
2014-12-01 2014-12-01 B Purchase MYERS STEVEN S Non-Executive Director
5,000 +8.4%
3.85
US$19,248 		5,000 +8.4% 3.85 US$19,248
2014-12-01 2014-11-28 B Purchase MYERS STEVEN S Non-Executive Director
5,000 +9.2%
3.99
US$19,946 		5,000 +9.2% 3.99 US$19,946
2014-11-26 2014-11-25 B Purchase MYERS STEVEN S Non-Executive Director
15,000 +38.1%
3.99
US$59,850 		15,000 +38.1% 3.99 US$59,850
2014-11-25 2014-11-25 B Purchase KLOSK STEVEN M Non-Executive Director
10,000 +inf%
3.99
US$39,850 		10,000 +inf% 3.99 US$39,850
2014-11-25 2014-11-24 B Purchase Pecora Andrew L

Chief Visionary Officer

Executive Director
12,500 +3.8%
4.01
US$50,150 		12,500 +3.8% 4.01 US$50,150
2014-11-25 2014-11-24 B Purchase MYERS STEVEN S Non-Executive Director
19,800 +101.4%
3.94
US$78,081 		19,800 +101.4% 3.94 US$78,081
2013-12-13 2013-12-12 S Sale BERMAN RICHARD J Non-Executive Director
12,218 -100.0%
5.99
US$73,125 		12,218 -100.0% 5.99 US$73,125
2013-12-10 2013-12-09 S Sale RimAsia Capital Partners Manager, Ltd. Large shareholder
12,096 -0.5%
6.37
US$77,052 		12,096 -0.5% 6.37 US$77,052
2013-12-10 2013-12-09 S Sale Wei Eric Non-Executive Director Large shareholder
12,096 -0.5%
6.37
US$77,052 		12,096 -0.5% 6.37 US$77,052
2013-12-10 2013-12-06 S Sale RimAsia Capital Partners Manager, Ltd. Large shareholder
434 -0.0%
6.35
US$2,756 		434 -0.0% 6.35 US$2,756
2013-12-10 2013-12-06 S Sale Wei Eric Non-Executive Director Large shareholder
434 -0.0%
6.35
US$2,756 		434 -0.0% 6.35 US$2,756
2013-11-29 2013-11-26 S Sale Wei Eric Non-Executive Director Large shareholder
10,000 -0.4%
6.26
US$62,620 		10,000 -0.4% 6.26 US$62,620
2013-11-29 2013-11-26 S Sale RimAsia Capital Partners Manager, Ltd. Large shareholder
10,000 -0.4%
6.26
US$62,620 		10,000 -0.4% 6.26 US$62,620
2013-11-25 2013-11-12 B Purchase MYERS STEVEN S Non-Executive Director
8,012 +inf%
6.25
US$50,075 		8,012 +inf% 6.25 US$50,075
2013-01-18 2012-12-28 S Sale BERMAN RICHARD J Non-Executive Director
96,577 -39.7%
0.59
US$57,386 		96,577 -39.7% 0.59 US$57,386
2013-01-18 2012-12-28 S Sale BERMAN RICHARD J Non-Executive Director
50,000 -17.0%
0.59
US$29,635 		50,000 -17.0% 0.59 US$29,635
2013-01-18 2012-12-27 S Sale BERMAN RICHARD J Non-Executive Director
2,729 -0.9%
0.61
US$1,665 		2,729 -0.9% 0.61 US$1,665
2012-09-18 2012-09-18 B Purchase Smith Robin L

Chairman of the Board and CEO

Executive Director
36,000 +2.1%
0.69
US$24,840 		36,000 +2.1% 0.69 US$24,840
2012-09-18 2012-09-18 S Sale BERMAN RICHARD J Non-Executive Director
36,000 -19.4%
0.69
US$24,840 		36,000 -19.4% 0.69 US$24,840
2011-12-19 2011-12-15 B Purchase Kolbert Jason

See Remarks

Officer
100 +1.3%
0.58
US$58 		100 +1.3% 0.58 US$58
2011-12-19 2011-12-15 B Purchase Kolbert Jason

See Remarks

Officer
2,900 +58.0%
0.59
US$1,699 		2,900 +58.0% 0.59 US$1,699
2011-12-15 2011-12-15 B Purchase Pecora Andrew L

Chief Medical Officer

Executive Director
10,000 +0.5%
0.60
US$6,000 		10,000 +0.5% 0.60 US$6,000
2011-12-15 2011-12-14 B Purchase Pecora Andrew L

Chief Medical Officer

Executive Director
40,000 +2.0%
0.59
US$23,600 		40,000 +2.0% 0.59 US$23,600
2011-12-15 2011-12-14 B Purchase Smith Robin L

Chairman of Board and CEO

Executive Director
50,000 +3.8%
0.60
US$29,890 		50,000 +3.8% 0.60 US$29,890
2011-12-13 2011-12-13 B Purchase Kolbert Jason

See Remarks

Officer
2,900 +138.1%
0.59
US$1,718 		2,900 +138.1% 0.59 US$1,718
2011-12-13 2011-12-13 B Purchase Kolbert Jason

See Remarks

Officer
1,100 +110.0%
0.59
US$651 		1,100 +110.0% 0.59 US$651
2011-12-13 2011-12-09 B Purchase Kolbert Jason

See Remarks

Officer
1,000 +inf%
0.56
US$557 		1,000 +inf% 0.56 US$557
2011-03-04 2011-03-03 B Purchase MYERS STEVEN S Non-Executive Director
195,313 +inf%
1.28
US$250,001 		195,313 +inf% 1.28 US$250,001
2011-03-04 2011-03-03 B Purchase Pecora Andrew L

See Remarks

Officer
78,125 +4.2%
1.28
US$100,000 		78,125 +4.2% 1.28 US$100,000
2011-03-04 2011-03-03 B Purchase MYERS STEVEN S Non-Executive Director
195,312 +28.1%
1.28
US$249,999 		195,312 +28.1% 1.28 US$249,999
2011-03-02 2011-02-28 B Purchase Smith Robin L

Chairman of the Board and CEO

Executive Director
6,136 +0.6%
1.28
US$7,854 		6,136 +0.6% 1.28 US$7,854
2010-08-20 2010-08-18 S Sale BERMAN RICHARD J Non-Executive Director
80,000 -100.0%
1.50
US$120,000 		80,000 -100.0% 1.50 US$120,000
2010-08-20 2010-08-18 B Purchase MYERS STEVEN S Non-Executive Director
80,000 +13.0%
1.50
US$120,000 		80,000 +13.0% 1.50 US$120,000
2010-02-22 2010-02-18 B Purchase RimAsia Capital Partners, L.P. Non-Executive Director Large shareholder
740,741 +6.4%
1.35
US$1,000,000 		740,741 +6.4% 1.35 US$1,000,000
2010-02-22 2010-02-18 B Purchase Wei Eric Non-Executive Director Large shareholder
740,741 +6.4%
1.35
US$1,000,000 		740,741 +6.4% 1.35 US$1,000,000
2010-02-22 2010-02-18 B Purchase MYERS STEVEN S Non-Executive Director
200,000 +48.3%
1.35
US$270,000 		200,000 +48.3% 1.35 US$270,000
2010-01-08 2010-01-08 B Purchase MYERS STEVEN S Non-Executive Director
137,728 +49.9%
1.09
US$150,124 		137,728 +49.9% 1.09 US$150,124
2010-01-08 2010-01-08 S Sale BERMAN RICHARD J Non-Executive Director
137,728 -63.3%
1.09
US$150,124 		137,728 -63.3% 1.09 US$150,124
2007-08-16 2007-08-14 B Purchase Smith Robin L

Chairman of the Board & CEO

Executive Director
3,300 +3.4%
16,500.00
US$54,450,000 		3,300 +3.4% 16,500.00 US$54,450,000
2007-02-08 2007-02-06 B Purchase Smith Robin L

Chairman and CEO

Executive Director
20,000
0.00
US$0 		20,000 0.00 US$0
2007-02-08 2007-02-06 B Purchase VACZY CATHERINE M

VP & Gen Counsel

Officer
20,000
0.00
US$0 		20,000 0.00 US$0
2007-01-30 2007-01-26 B Purchase Smith Robin L

Chairman and CEO

Executive Director
200,000
0.00
US$0 		200,000 0.00 US$0
2006-06-06 2006-06-05 S Sale Aholt Jr Family Trust Large shareholder
300,000 -2.4%
0.06
US$18,000 		300,000 -2.4% 0.06 US$18,000
2006-06-06 2006-06-02 B Purchase Smith Robin L

Chairman and CEO

Executive Director
500,000 +14.3%
0.04
US$22,000 		500,000 +14.3% 0.04 US$22,000
2006-04-06 2006-04-04 B Purchase May Larry Alan

Chief Financial Officer

Officer
200,000 +83.3%
0.05
US$10,600 		200,000 +83.3% 0.05 US$10,600
2005-12-23 2005-12-22 B Purchase VACZY CATHERINE M

EVP and General Counsel

Officer
416,666 +7.9%
0.06
US$25,000 		416,666 +7.9% 0.06 US$25,000
2005-12-02 2005-11-30 B Purchase WEINREB MARK

President & CEO

Executive Director
595,000
0.00
US$0 		595,000 0.00 US$0
2005-12-02 2005-11-30 B Purchase ZUCKERMAN JOSEPH Non-Executive Director
425,000
0.00
US$0 		425,000 0.00 US$0
2005-12-02 2005-11-30 B Purchase VACZY CATHERINE M

Exec. V.P. & General Counsel

Officer
1,700,000
0.00
US$0 		1,700,000 0.00 US$0
2005-10-05 2005-10-03 B Purchase VACZY CATHERINE M

Executive VP and Gen. Counsel

Officer
260,817 +7.8%
0.04
US$10,433 		260,817 +7.8% 0.04 US$10,433
2005-08-18 2005-08-16 B Purchase MARASCO WAYNE A

Senior Scientific Advisor

Executive Director
833,333 +166.7%
0.06
US$50,000 		833,333 +166.7% 0.06 US$50,000
Explore more

More insider trading research around Lisata Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America